Protective Vascular Treatment of Patients with Peripheral Arterial Disease: Guideline Adherence According to Year, Age and Gender
Authors:
- 1 January 2010
- journal article
- research article
- Published by Springer Nature in Canadian Journal of Public Health
- Vol. 101 (1) , 96-100
Abstract
To evaluate vasoprotective pharmacological treatment of patients with peripheral arterial disease (PAD) according to: 1) year, 2) age and 3) gender.Keywords
This publication has 47 references indexed in Scilit:
- Gender Disparities in Blood Pressure Control and Cardiovascular Care in a National Sample of Ambulatory Care VisitsHypertension, 2008
- Prevalence and Risk Factors of Peripheral Arterial Disease in a Selected Thai PopulationAngiology, 2007
- Gender differences in the clinical management of patients with angina pectoris: a cross-sectional survey in primary careBMC Health Services Research, 2007
- A cross sectional survey of secondary prevention measures in patients with peripheral arterial disease in primary care2007
- Impact of specialty of admitting physician and type of hospital on care and outcome for myocardial infarction in England and Wales during 2004-5: observational studyBMJ, 2006
- Evidence for Age and Sex Differences in the Secondary Prevention of Stroke in Scottish Primary CareStroke, 2005
- Evidence for inequalities in the management of coronary heart disease in ScotlandHeart, 2005
- MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebocontrolled trialThe Lancet, 2002
- Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)JAMA, 2001
- Atherosclerotic Risk Factors Are Less Intensively Treated in Patients with Peripheral Arterial Disease Than in Patients with Coronary Artery DiseaseJournal of General Internal Medicine, 1997